Año: 2022
Journal Impact Factor (JIF): 11.20
Categoría | Edición | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|---|
ONCOLOGY | SCIE | 26/241 | Q1 | T1 | D2 |
Año: 2022
Journal Citation Indicator (JCI): 1,930
Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
---|---|---|---|---|---|
ONCOLOGY | 28/318 | Q1 | T1 | D1 | 91,35 |
Año:
2022
CiteScore:
16,900
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Cancer Research | 19/214 | Q1 | T1 | D1 |
Oncology | 25/366 | Q1 | T1 | D1 |
SJR año:
2022
Factor de Impacto:
2,984
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Cancer Research | 20/231 | Q1 | T1 | D1 |
Oncology | 26/397 | Q1 | T1 | D1 |
Agencia | Código de Proyecto |
---|---|
BCRF Drug Research Collaborative | - |
ESSCO Breast Cancer Research Fund | - |
Harvard Medical School Eleanor and Miles Shore Fellowship | - |
Howard Hughes Medical Institute | - |
National Foundation for Cancer Research | - |
NIH/NCI | U01CA214297; 2R01CA129933 |
NIH/NIBIB | EB012493 |
NIHP41 BioMEMS Resource Center | EB002503 |
Shriners Hospital for Children Mass Spectrometry Special Shared Facility | - |
Tosteson & Fund for Medical Discovery Fellowship | - |
# | Autor |
---|---|
1 | Karabacak, NM |
2 | Zheng, Y |
3 | Dubash, TD |
4 | Burr, R |
5 | Micalizzi, DS |
6 | Wittner, B |
7 | Lin, MX |
8 | Wiley, DF |
9 | Comaills, V |
10 | Emmons, E |
11 | Niederhoffer, KL |
12 | Ho, U |
13 | Ukleja, J |
14 | Che, D |
15 | Stowe, H |
16 | Nieman, LT |
17 | Haas, W |
18 | Stott, SL |
19 | Lawrence, MS |
20 | Ting, DT |
21 | Miyamoto, DT |
22 | Haber, DA |
23 | Toner, M |
24 |